Advertisement
Singapore markets close in 4 hours 48 minutes

  • Straits Times Index

    3,284.71
    -8.42 (-0.26%)
     

  • Nikkei

    37,701.29
    -758.79 (-1.97%)
     

  • Hang Seng

    17,293.72
    +92.45 (+0.54%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Bitcoin USD

    64,112.44
    -2,528.94 (-3.79%)
     

  • CMC Crypto 200

    1,389.87
    -34.23 (-2.40%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Gold

    2,325.80
    -12.60 (-0.54%)
     

  • Crude Oil

    82.88
    +0.07 (+0.08%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • FTSE Bursa Malaysia

    1,570.12
    -1.36 (-0.09%)
     

  • Jakarta Composite Index

    7,150.62
    -23.92 (-0.33%)
     

  • PSE Index

    6,579.98
    +7.23 (+0.11%)
     

Pfizer in talks over full license for COVID-19 vaccine in Singapore

Reuters
Updated
Pfizer in talks over full license for COVID-19 vaccine in Singapore

SINGAPORE, Sept 24 (Reuters) - Pfizer Inc is in discussions with Singapore's Health Sciences Authority regarding obtaining a full license application for its COVID-19 vaccine, the company said in response to a query from Reuters.

Pfizer-BioNTech's COVID-19 vaccine has interim authorisation under the pandemic special access route in Singapore. The U.S. Food and Drug Administration granted full approval to the vaccine last month.

(Reporting by Aradhana Aravindan in Singapore Editing by Ed Davies)